Off-Label Prescriptions in Dermatology: Challenges of New Routes of Administration for Certain Old Drugs

被引:1
|
作者
Tasic-Kostov, Marija [1 ]
Ilic, Dusan [1 ]
机构
[1] Univ Nis, Fac Med, Dept Pharm, Nish, Serbia
关键词
off-label drug; dermatology; compounded drugs; drug vehicle; INFANTILE HEMANGIOMAS; TOPICAL PROPRANOLOL; SPIRONOLACTONE; THERAPY; SAFETY; ACNE; GEL;
D O I
10.5937/afmnai37-25282
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
"Off-label drug use" refers to the prescription of medications, with reference to indications, dosage, dosage form, patient group or route of administration, which are officially unapproved. Recently, new indications for some drugs have emerged and few of them are being used off-label to treat topically a variety of dermatological conditions. Off-label use is more common in dermatology than in other medical specialties, and those drugs are basically available as compounded formulations, but the choice of a proper vehicle and safety of extemporaneous drug preparation intended for topical use are usually neglected in case of systemic drugs. Moreover, the bases commonly used as vehicles for extemporaneous dermatological preparations are stabilized with traditional surfactants known for their potential to irritate skin, while inflammatory dermatoses can worsen when exposed to irritants In this paper, we have listed several systemic drugs which are being used in topical treatment of some frequent dermatological conditions, but not according to their officially approved indications. The choice of drugs was made according to the topical off-label dermatological prescriptions obtained from public pharmacies. The aim was also to review data related to, in our opinion, two major drawbacks of using off-label topical drugs: safety data on the use of the final dermal preparation and scientific information relevant for the choice of a proper topical vehicle for specific drug and proper stability evaluation.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 43 条
  • [1] Controversies in off-label prescriptions in dermatology: the perspective of the patient, the physician, and the pharmaceutical companies
    Franca, Katlein
    Litewka, Sergio
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2019, 58 (07) : 788 - 794
  • [2] Pertinence of Off-label Prescriptions of Innovating and Expensive Drugs in a University Hospital
    Falabregues, Amelie
    Daul, Marion
    Pourroy, Bertrand
    Gauthier-Villano, Laurence
    Pisano, Pascale
    Rathelot, Pascal
    Vialettes, Bernard
    THERAPIE, 2015, 70 (05): : 385 - 402
  • [3] Retapamulin Prescriptions and Monitored Off-Label Use
    Mundy, Linda M.
    Sampson, Tim
    Logie, John W.
    PEDIATRIC DRUGS, 2014, 16 (04) : 331 - 336
  • [4] Off-label studies on apremilast in dermatology: a review
    Maloney, Nolan J.
    Zhao, Jeffrey
    Tegtmeyer, Kyle
    Lee, Ernest Y.
    Cheng, Kyle
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (02) : 131 - 140
  • [5] Off-label drugs in childhood psoriasis
    Mahe, E.
    Corgibet, F.
    Maccari, F.
    Hadj-Rabia, S.
    Phan, C.
    Ruer-Mulard, M.
    Boralevi, F.
    Barbarot, S.
    Bursztejn, A-C
    Lahfa, M.
    Severino-Freire, M.
    Aubin, F.
    Barthelemy, H.
    de la Breteque, M. Amy
    Beauchet, A.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2020, 147 (6-7): : 429 - 438
  • [6] Off-Label Use of Cancer Drugs: A Benchmark Is Established
    Krzyzanowska, Monika K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (09) : 1125 - 1127
  • [7] Off-Label Use of Spesolimab in Dermatology: A Systematic Review
    Sood, Siddhartha
    Waked, Jihad
    Merchant, Nabil
    Abduelmula, Abrahim
    Mufti, Asfandyar
    Yeung, Jensen
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2025,
  • [8] Off-label Use of Azathioprine in Dermatology A Systematic Review
    Schram, Mandy E.
    Borgonjen, Rinke J.
    Bik, Cathelijne M. J. M.
    van der Schroeff, Jan G.
    van Everdingen, Jannes J. E.
    Spuls, Phyllis I.
    ARCHIVES OF DERMATOLOGY, 2011, 147 (04) : 474 - 488
  • [9] Challenges of studying drugs in pregnancy for off-label indications: Pravastatin for preeclampsia prevention
    Cleary, Kirsten Lawrence
    Roney, Kelly
    Costantine, Maged
    SEMINARS IN PERINATOLOGY, 2014, 38 (08) : 523 - 527
  • [10] An In-depth Review of the Off-label Use of Apremilast in Dermatology
    Bubna, Aditya Kumar
    Viplav, Vinayak
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2024,